Brind.

Eli Lilly provided a strategic equity investment to Absci Corporation, which is led by Sean McClain.

2 reports, 2 independent Updated Aug 11
Gone quiet Reached 2 outlets in its first 24 hours
Reports
2
Developments
2
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Eli Lilly provided a strategic equity investment to Absci Corporation, which is led by Sean McClain.

Who's involved

What this event is mainly about
Eli Lilly and CompanySean McClain

How it developed

Newest first. Tap a step to see who reported it.
  1. Lilly invests $40M and collaborates on clinical development with Absci.1 source
  2. Eli Lilly invests in Absci Corporation, a company founded by Sean McClain.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped